Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...
The EU has said it plans to roll out over a six-month period a new Entry/Exit System, dubbed EES, that will require the ...
This privacy impact assessment (PIA) assesses the privacy implications of collecting information from users of Aotearoa Data Explorer.Download the ...
More than 260,000 California second graders are starting the school year with more than pencils and backpacks—they’re also receiving their first college savings scholarship through CalKIDS, the state ...
Oregon Ducks unveil special "Mummy Duck" glow-in-the-dark uniforms featuring phosphorescent accessories for Saturday's, ...
The British government has confirmed plans to introduce a nationwide digital identification system, a move Prime Minister ...
The Food and Drug Administration (FDA) has expanded the approval of Evkeeza ® (evinacumab-dgnb) to include children aged 1 year and older with homozygous familial hypercholesterolemia (HoFH).
The signing by Polish President Karol Nawrocki of the law on temporary protection for Ukrainian citizens who fled the war ...
Hong Kong-based artists, Riya Chandiramani and Sai Pradhan, have turned Ping Pong 129 Gintonería into a canvas for their new ...
Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...
Deputy Minister of Economy, Environment, and Agriculture of Ukraine, Denys Bashlyk, met with a delegation from the UN World ...
The Food and Drug Administration (FDA) has approved Palsonify ™ (paltusotine) for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback